29 August 2016
AsiaNews.it Twitter AsiaNews.it Facebook
Geographic areas




  • > Africa
  • > Central Asia
  • > Europe
  • > Middle East
  • > Nord America
  • > North Asia
  • > South Asia
  • > South East Asia
  • > South West Asia
  • > Sud America
  • > East Asia

  • mediazioni e arbitrati, risoluzione alternativa delle controversie e servizi di mediazione e arbitrato


    » 10/11/2012, 00.00

    JAPAN

    Nobel Prize for Yamanaka, scientific research and ethics must go hand in hand

    Pino Cazzaniga

    Research on iPS (induced pluripotent stem cells) can produce stem cells from adult cells, for use in regenerative medicine. Shinya Yamanaka’s discovery reveals that research on embryonic stem cells is unnecessary, saving the lives of many embryos. The Japanese researcher has searched for new ways driven by ethical question.

    Tokyo (AsiaNews) - Shinya Yamanaka, fresh from the Nobel Prize for medicine, states that science and ethics must go hand in hand. Interviewed by the Mainichi Shimbun after the award, he said: "I would like to invite ethical experts as teachers at my laboratory and work to guide iPS [induced pluripotent stem] cell research from that direction as well. The work of a scientific researcher is just one part of the equation. "

    Yamanaka, 50, found that adult cells can be transformed into cells in their infancy, stem cells (iPS), which are, so to speak, the raw material for the reconstruction of tissue irreparably damaged by disease. For regenerative medicine the implications of Yamanaka's discovery are obvious. Adult skin cells can for example be reprogrammed and transformed into any other cell that is desired: from the skin to the brain, from the skin to the heart, from the skin to elements that produce insulin.

    "Their discovery - says the statement of the jury that awarded him the Nobel Prize on October 8 - has revolutionized our understanding of how cells and organisms develop. Through the programming of human cells, scientists have created new opportunities for the study of diseases and development of methods for the diagnosis and therapy ".

    These "opportunities" are not only "scientific", but also "ethical". Much of the scientific research and global investment is in fact launched to design and produce stem cells from embryos, arriving at the point of manipulating and destroying them, facing scientists with enormous ethical problems.

    " Ethics are really difficult - Yamanaka explainsto Mainichi - In the United States I began work on mouse experiments, and when I returned to Japan I learned that human embryonic stem cells had been created. I was happy that they would contribute to medical science, but I faced an ethical issue. I started iPS cell research as a way to do good things as a researcher, and I wanted to do what I could to expand the merits of embryonic stem cells. If we make sperm or eggs from iPS cells, however, it leads to the creation of new life, so the work I did on iPS cells led to an ethical problem. If we don't prepare debates for ethical problems in advance, technology will proceed ahead faster than we think.. "

    The "ethical question" Yamanaka pushed to find a way to "not keep destroying embryos for our research."

    Speaking with his co-workers at the University of Kyoto, immediately after receiving the award, Yamanaka showed dedication and modesty.

    "Now - he said - I strongly feel a sense of gratitude and responsibility" gratitude for family and friends who have supported him in a demanding journey of discovery that lasted decades; responsibility for a discovery that gives hope to millions of patients. Now iPS cells can grow into any tissue of the human body allowing regeneration of parts so far irretrievably lost due to illness.

    His modesty also led him to warn against excessive hopes. To a journalist who asked him for a message to patients and young researchers awaiting the results of his research heresponded: "The iPS cells are also known as versatile cells, and the technology may be giving the false impression to patients that they could be cured any day now. It will still take five or 10 years of research before the technology is feasible. There are over 200 researchers at my laboratory, and I want patients to not give up hope"

     "Dozens of times - he continued - I tried to get some results and I have often failed in the experiments .... Many times I was tempted to give up or cry. Without the support of my family, I could not have continued this search. From now on I will be facing the moment of truth. I would like to return to my laboratory as quickly as possible. "

    Mainichi celebrated the new Nobel Laureate, saying emphatically that Yamanaka has "reversed the cycle of life" until now, scientists thought that new life could only be born from embryos. But to do this means manipulating and killing life itself. With Yamanaka's discovery, old cells, can regenerate, and save embryos. "A process that is considered irreversible" instead revealed the existence of a new life cycle.

     

    e-mail this to a friend Printable version










    See also

    21/06/2010 ASIA
    Damage from stem cell therapy. Caution never hurts
    The death of a person treated with stem cells has created debate among scholars. Caution is required, because although there is a lot of promising data in various fields of application, not all types of stem cells have demonstrated real therapeutic potential. Above all the good of the person must take first place.

    17/08/2005 SOUTH KOREA
    Korean bishops urge prayers for national unity and Christian rebirth
    Messages to the faithful are issued for the Solemnity of the Assumption and the Day of Liberation from Japanese rule.

    22/05/2008 SOUTH KOREA
    Church: no to bioethics law, it permits sale of human eggs
    The revisions to the draft law, approved by parliament, provide "expense reimbursement" for those who donate human eggs. Scorching commentary from the bishops' commission for bioethics, which speaks of "an enormous step backward". In the meantime, the "pioneer of cloning" announces: four cloned puppies in good health.

    30/04/2009 SOUTH KOREA
    Seoul lifts ban on human stem cell research
    Researchers in South Korea’s capital can conduct human stem cell research if they respect four conditions. Only eggs from aborted foetuses can be used. Research on human stem cells had stopped three years ago in the wake of the scandal that swept the phoney pioneer of human cloning. South Korea is now following the lead of the United States.

    21/02/2009 VATICAN
    Pope: Man is greater than his genetic makeup and physical perfection
    Receiving the members of the Pontifical Academy for Life, Benedict XVI reaffirms the absolute value of the human person, against those who would like to use eugenics to eliminate all those who are sick or imperfect. It is necessary to fight "genetic reductionism," because man is greater than his physical body.



    Editor's choices

    CHINA - VATICAN
    In China-Holy See talks, silence shrouds future of underground priests

    Zhao Nanxiong

    Later this year, all priests must register to receive a certificate that allows them to exercise their ministry. But the request has to go through the Patriotic Association, whose statutes are "incompatible" with Catholic doctrine. Many priests, official and unofficial, now face an enormous dilemma.


    IRAQ
    Alqosh, despite the Islamic State, the Church celebrates the first communion of one hundred children



    On the feast day of the Assumption the whole community attended the function, celebrated by Mar Sako. For the patriarchal vicar, this is an historic moment for the frontier town long threatened by jihadists. The Chaldean primate calls on children to "contribute to the community." In Kirkuk His Beatitude opened a grotto dedicated to Our Lady.


    AsiaNews IS ALSO A MONTHLY!

    AsiaNews monthly magazine (in Italian) is free.
     

    SUBSCRIBE NOW

    News feed

    Canale RSScanale RSS 

    Add to Google









     

    IRAN 2016 Banner

    2003 © All rights reserved - AsiaNews C.F. e P.Iva: 00889190153 - GLACOM®